NEUP

Neuphoria Therapeutics Inc. Common Stock

9 hedge funds and large institutions have $2.06M invested in Neuphoria Therapeutics Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
LCM
1
Lynx1 Capital Management
Puerto Rico
$1.22M +$13K +733 +1%
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$490K -$489K -27,553 -50%
Morgan Stanley
3
Morgan Stanley
New York
$281K +$281K +15,828 New
Two Sigma Investments
4
Two Sigma Investments
New York
$46.3K +$46.3K +2,606 New
XT
5
XTX Topco
Cayman Islands
$17.8K +$17.8K +986 New
TRCT
6
Tower Research Capital (TRC)
New York
$2.38K +$2.29K +129 +2,580%
RhumbLine Advisers
7
RhumbLine Advisers
Massachusetts
$757
UBS Group
8
UBS Group
Switzerland
$487 -$3.25K -180 -87%
APC
9
Aspire Private Capital
North Carolina
$296
TCM
10
Tang Capital Management
California
-$1.89M -58,333 Closed
OCA
11
Octagon Capital Advisors
New York
-$454K -14,000 Closed
BI
12
BVF Inc
California
-$128K -3,948 Closed
VF
13
Virtu Financial
New York
-$45K -1,380 Closed
FIA
14
FNY Investment Advisers
New York
-$5K -177 Closed